microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients.

导出 LinkOut

翻译打印收藏纠错

作者： Ashraf,Bakkar ^[1] ; Mohammed,Alshalalfa ^[2] ; Lars F,Petersen ^[3] ; Hatem,Abou-Ouf ^[1] ; Amal,Al-Mami ^[1] ; Samar A,Hegazy ^[1] ; Felix,Feng ^[1] ; Reda,Alhajj ^[4] ; Krikor,Bijian ^[3] ; Moulay A,Alaoui-Jamali ^[5] ; Tarek A,Bismar ^[5]

作者单位： Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB, T2V 1P9, Canada. ^[1] Faculty of Biotechnology, October University of Modern Sciences and Arts, Giza, Egypt. ^[2] Department of Computer Science, University of Calgary, Calgary, AB, Canada. ^[3] Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. ^[4] Departments of Medicine and Oncology, McGill University and Segal Cancer Centre of the Jewish General Hospital, Montreal, QC, Canada. ^[5] Departments of Oncology, Biochemistry and Molecular Biology, Calgary, AB, Canada. tarek.bismar@cls.ab.ca. ^[6] Southern Alberta Cancer Institute and Tom Baker Cancer Center, Calgary, AB, Canada. tarek.bismar@cls.ab.ca. ^[7] Rockyview General Hospital, Department of Pathology, 7007 14th st sw, Calgary, AB, T2V 1P9, Canada. tarek.bismar@cls.ab.ca. ^[8]

关键词 CXCR axis ERG gene rearrangements Invasion MiR338-3p Prognosis Prostate cancer